Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hepatitis E subunit vaccine

A subunit vaccine, hepatitis E virus technology, applied in the direction of positive-sense single-stranded RNA virus, antibody medical components, peptide sources, etc., can solve the problems of interfering with epidemic monitoring, difficulty in strain cultivation, affecting the effect of virus protection, and achieving The detection method is convenient and accurate, with high antigen stability and specificity.

Active Publication Date: 2019-07-16
YEBIO BIOENG OF QINGDAO
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional inactivated vaccines have unique advantages such as uniformity of antibodies after immunization and high antibody titers, but there are also difficulties in cultivating the strains used to make vaccines, and there is a large difference in antigenicity from clinically popular strains, which affects the challenge. The shortcomings of the protective effect restrict the application of inactivated vaccines
Moreover, antibodies produced after immunization with traditional vaccines prepared with whole virus antigens cannot be clinically distinguished from wild virus infection or vaccine immunization, which will interfere with the monitoring of the epidemic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hepatitis E subunit vaccine
  • Hepatitis E subunit vaccine
  • Hepatitis E subunit vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1: Amplification and sequence analysis of ORF2 gene

[0020] In 2018, suspected hepatitis E occurred in some broiler breeders from Dalian. After clinical investigation and laboratory testing, it was initially diagnosed as hepatitis E. After investigation, the above-mentioned sick flocks had been injected with hepatitis E vaccine before, and had also been tested for neutralizing antibodies. It is suspected that the hepatitis E virus has mutated under the selection pressure of the vaccine, and the hepatitis E virus QD07 strain was isolated from the sick chicken disease feed sample as the template for amplification.

[0021] 1. Amplification of the HEV ORF2 gene

[0022] According to the hepatitis E virus ORF2 gene sequence published in NCBI, primers were designed and synthesized. The sequence information of the primers is as follows:

[0023] primer1: 5′-ATGTCGGTGCGTGGATTGTTGCTC-3′;

[0024] primer2: 5'-CTAGGGTGGTGAGGGAAACGT-3'.

[0025] The nucleic acid of...

Embodiment 2

[0032] Example 2: Recombinant expression of hepatitis E virus ORF2 protein

[0033] 1. Preparation method of ORF2 protein

[0034] The method comprises the following steps: a. constructing an expression vector; b. constructing an expression strain; c. induction, extraction and purification of the recombinant ORF2 protein.

[0035] a. Construct expression vector:

[0036] The positive clone plasmid pMD18-T-ORF2 and the expression vector pET28a vector were digested with EcoRI and NotI, respectively, and the products were subjected to 1.2% agarose gel electrophoresis, and then recovered with a DNA gel recovery kit to obtain about 5400bp and 850bp fragments, respectively. The pET28a expression vector was constructed by directional ligation at 16°C; after the sequence and reading frame were verified by sequencing, the plasmid was linearized and transformed into BL21 competent cells.

[0037] b. Construction of expression strains, protein extraction and purification:

[0038] Aft...

Embodiment 3

[0040] Embodiment 3: the preparation of subunit vaccine

[0041] 1. Subunit vaccine preparation

[0042] 1. Preparation of ORF2 protein for seedling production

[0043]The BL21-ORF2 strain was inoculated in LB liquid medium containing kanamycin, cultured with shaking at 30°C for 18 hours, quantitatively distributed, and after pure inspection, it was used as the first-class seed. Take the first-grade seeds and inoculate them in LB liquid medium, culture them with shaking at 37°C for 18 hours, and store them at 2-8°C after microscopic examination. Add LB liquid medium according to 60% (V / V) of the volume of the fermenter, and at the same time add antifoaming agent according to 0.1% (V / V) of the medium, pass through high-temperature steam to sterilize for 30 minutes, and wait until the temperature of the medium drops to 37°C , inoculated with the secondary seed solution for ORF2 protein production, the parameters of the fermenter were set to stir at 800r / min, temperature at 37°...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a hepatitis E subunit vaccine. The antigen protein of the hepatitis E subunit vaccine is hepatitis E virus ORF2 protein of which the amino acid sequence is SEQID NO:2 or SEQID NO:4. The subunit vaccine prepared from the hepatitis E ORF2 protein has the characteristics of being high in antigen stability, high in purity, high in specificity and convenient and accurate in detection method, and other uncorrelated antibodies are not produced, and a firm foundation is established for industrialized production of a hepatitis E vaccine and a diagnosis reagent.

Description

technical field [0001] The invention belongs to the technical field of veterinary biological products, in particular to a hepatitis E subunit vaccine. Background technique [0002] Hepatitis E is an infectious disease caused by hepatitis E virus (Hepatitis E Virus, HEV), mainly transmitted through the intestinal tract, and has the clinical and epidemiological characteristics of acute viral hepatitis. Viral hepatitis that seriously endangers human health. Hepatitis E is currently prevalent in my country and many developing countries, and sporadic in a few developed countries. HEV is a zoonotic virus. It has been reported that HEV can infect various animals such as chickens, deer and rabbits under natural conditions. Hepatitis E can reduce egg production by more than 20% in some outbreak flocks. The HS syndrome mortality rate of laying broiler breeders and laying hens aged 30 to 72 weeks was higher than normal, and the incidence rate was highest at 40 to 50 weeks of age. A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/29A61P31/14A61P1/16
CPCA61K39/12A61P31/14C12N2770/28134C07K14/005G01N33/6893G01N33/5767C12N2770/28122G01N2333/08
Inventor 郭伟伟向银辉蔡联燊刘新文刘义范根成杜元钊
Owner YEBIO BIOENG OF QINGDAO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com